Earnings Scheduled For December 15, 2022
Companies Reporting Before The Bell
• Trinity Biotech (NASDAQ:TRIB) is expected to report quarterly loss at $0.04 per share on revenue of $19.50 million.
Trinity Biotech’s Earnings: A Preview
Trinity Biotech (NASDAQ:TRIB) is set to give its latest quarterly earnings report on Thursday, 2022-12-15. Here’s what investors…
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell
• Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
Trinity Biotech Announces Results Of Annual General Meeting
On September 30, 2022 Trinity Biotech plc held an AGM of Shareholders at the Company's headquarters at IDA Business Park, Bray, Co. Wicklow, Ireland.
At the AGM, the Company's shareholders approved the following
Trinity Biotech Announces CE Mark Of Its 10-Minute Covid-19 Antigen Test
Trinity Biotech plc (NASDAQ:TRIB) has achieved a CE Mark for its 10-minute Covid-19 antigen test. This CE mark allows for use by healthcare professionals and trained users. The Company intends to launch the test
12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers
Hoth Therapeutics (NASDAQ:HOTH) stock rose 156.5% to $1.58 during Monday's pre-market session. The market value of their outstanding shares is at $37.8 million.
Trinity Biotech Q4 Sales $19.52M Down From $32.77M YoY
Trinity Biotech (NASDAQ:TRIB) reported $19.52 million in sales this quarter. This is a 40.41 percent decrease over sales of $32.77 million the same period last year.
Trinity Biotech Announces A $45M Strategic Investment And Partnership With The MiCo Group Of South Korea
Trinity Biotech plc (NASDAQ:TRIB), a leading global diagnostic company ("Trinity Biotech" or the "Company"), today announced a $45 million strategic investment and partnership with MiCo Ltd
